Strategies for managing the risks associated with ADHD medications
1From the Department of Family Medicine, University of North Carolina, Chapel Hill, and the Mood Disorders Clinic, Moses Cone Family Practice Center, Greensboro, North Carolina.
The Journal of Clinical Psychiatry
|October 11, 2013
Summary
College students with Attention-Deficit/Hyperactivity Disorder (ADHD) require comprehensive treatment, including accurate diagnosis, patient education, and careful medication management to address academic and organizational challenges. Ongoing monitoring is crucial to prevent misuse and ensure treatment efficacy.
Area of Science:
- Clinical Psychology
- Neurodevelopmental Disorders
- Higher Education Medicine
Background:
- College students with Attention-Deficit/Hyperactivity Disorder (ADHD) face significant challenges in academic performance, organization, and time management.
- Effective management of ADHD symptoms is critical for student success and well-being.
Purpose of the Study:
- To outline essential clinical strategies for assessing and treating college students diagnosed with ADHD.
- To emphasize the importance of patient education and medication adherence in managing ADHD.
Main Methods:
- Utilizing rating scales for accurate assessment of ADHD and comorbid conditions.
- Educating patients on treatment responsibilities and proper medication use.
- Considering nonstimulant or long-acting stimulant options for patients with a history of substance use.
- Implementing regular monitoring through office visits and random testing for symptom and side-effect management.
Main Results:
- Proper assessment and patient education are key components of successful ADHD treatment in college students.
- Tailored medication strategies, considering substance use history, are necessary.
- Continuous monitoring helps mitigate risks of medication misuse and ensures treatment effectiveness.
Conclusions:
- A multifaceted approach involving accurate diagnosis, patient empowerment, careful medication selection, and vigilant monitoring is essential for effectively treating college students with ADHD.
- Addressing comorbid conditions and substance use history is vital for comprehensive care.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.4K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
9.7K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:28Drug Therapy
450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
450
01:24Drug Toxicity: Risk factors
250
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
250
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
933
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
933
01:28Dosage Regimens: Designs and Approaches
605
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
605